| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 76,161 | 86,643 | 80,423 | 83,518 | | Cost of Revenue | 18,807 | 19,759 | 19,570 | 19,942 | | | Gross Profit |
-
| 66,884 | 60,853 | 63,576 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,857 | 36,841 | 31,701 | 32,028 | | Non Recurring |
-
|
-
| 152,502 | 1,410 | | Others | 2,149 | 12,577 | 7,394 | 9,306 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 17,466 | (130,744) | 20,832 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 20,348 | 17,466 | (130,744) | 20,832 | | Interest Expense | 8,922 | 9,388 | 9,956 | 10,787 | | Income Before Tax | 11,426 | 8,078 | (140,700) | 10,045 | | Income Tax Expense | 2,750 | 1,733 | 2,919 | 2,612 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,676 | 6,345 | (143,619) | 7,433 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,676 | 6,345 | (143,619) | 7,433 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,676 | $6,345 | ($143,619) | $7,433 |
|
0.31% Nasdaq 0.00%
Income Statement
